| United Prosthetics Inc | |
| 300 Congress St, Ste 404, Quincy, Massachusetts 02169 | |
| (617) 436-6110 |
| Name | United Prosthetics Inc |
|---|---|
| Organization Name | United Prosthetics Inc |
| Location | 300 Congress St, Ste 404, Quincy, Massachusetts 02169 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (617) 436-6110 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a recent DECODED Online entry, Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides an overview of the CRISPR/Cas9 system to scientists looking to enhance their genome modification strategy in model organisms or cell lines.
The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine, today (Nov. 5) announced the launch of a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder.
Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have demonstrated for the first time the selective cytotoxicity of Bacillus thuringiensis subsp. israelensis Cry4B toxin is mediated by BT-R3.
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.
› Verified 2 days ago
| NPI Number | 1720511934 |
| Organization Name | UNITED PROSTHETICS INC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 300 Congress St, Suite 404, Quincy, MA 02169 |
| Phone Number | 617-436-6110 |
News Archive
In a recent DECODED Online entry, Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides an overview of the CRISPR/Cas9 system to scientists looking to enhance their genome modification strategy in model organisms or cell lines.
The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine, today (Nov. 5) announced the launch of a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder.
Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have demonstrated for the first time the selective cytotoxicity of Bacillus thuringiensis subsp. israelensis Cry4B toxin is mediated by BT-R3.
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.
› Verified 2 days ago
News Archive
In a recent DECODED Online entry, Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, provides an overview of the CRISPR/Cas9 system to scientists looking to enhance their genome modification strategy in model organisms or cell lines.
The West Virginia University Rockefeller Neuroscience Institute and WVU Medicine, today (Nov. 5) announced the launch of a first-in-the-U.S. clinical trial using deep brain stimulation for patients suffering from treatment-resistant opioid use disorder.
Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have demonstrated for the first time the selective cytotoxicity of Bacillus thuringiensis subsp. israelensis Cry4B toxin is mediated by BT-R3.
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor. Aromatase inhibitors are a class of chemotherapeutic agents that block the production of estrogen in postmenopausal women.
› Verified 2 days ago
Cvs Pharmacy #02454 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 321 Quincy Shore Dr, Quincy, Massachusetts 02171 Phone: (617) 471-0041 | |
Cvs Pharmacy #00137 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 626 S Artery, Quincy, Massachusetts 02169 Phone: (617) 472-7534 | |
Walgreens #18361 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 132 Granite St, Quincy, Massachusetts 02169 Phone: (617) 479-2330 | |
Stop & Shop Pharmacy # 20 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 65 Newport Ave, Quincy, Massachusetts 02171 Phone: (617) 328-6622 | |
Walgreens #04403 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 418 Quincy Ave, Quincy, Massachusetts 02169 Phone: (617) 472-4483 |